Literature DB >> 9516299

Developing an integrated information system for specialized addiction treatment agencies.

A C Ogborne1, K Braun, B R Rush.   

Abstract

This article outlines the development of an integrated information system for specialized alcohol and drug treatment agencies in Ontario, Canada. The system is being developed following a strategic planning process involving provincial funding ministries and coalitions of service providers. An overview of the system's development is provided and the implementation of one subcomponent, a client-tracking system, is described. Some challenges to the implementation of this component are identified.

Entities:  

Mesh：

Year:  1998        PMID： 9516299     DOI： 10.1007/bf02287505

Source DB:  PubMed          Journal:  J Behav Health Serv Res        ISSN： 1094-3412            Impact factor:   1.505


  6 in total

1.  Substance abuse treatment management information systems: balancing federal, state, and service provider needs.

Authors:  J M Camp; M Krakow; D McCarty; M Argeriou
Journal:  J Ment Health Adm       Date:  1992

2.  The development of patient profiles for Minnesota's treatment outcomes monitoring system.

Authors:  P A Harrison; T J Beebe; J A Fulkerson; C R Torgerud
Journal:  Addiction       Date:  1996-05       Impact factor: 6.526

Review 3.  The cost effectiveness of treatment for alcoholism: a first approximation.

Authors:  H Holder; R Longabaugh; W R Miller; A V Rubonis
Journal:  J Stud Alcohol       Date:  1991-11

Review 4.  Specialized addictions assessment/referral services in Ontario: a review of their characteristics and roles in the addiction treatment system.

Authors:  A C Ogborne; B R Rush
Journal:  Br J Addict       Date:  1990-02

5.  Overcoming barriers to identification and referral of alcoholics in a general hospital setting: one approach.

Authors:  C N Williams; D C Lewis; J Femino; L Hall; K Blackburn-Kilduff; R Rosen; C Samella
Journal:  R I Med J       Date:  1985-03

Review 6.  Barriers to the care of persons with dual diagnoses: organizational and financing issues.

Authors:  M S Ridgely; H H Goldman; M Willenbring
Journal:  Schizophr Bull       Date:  1990       Impact factor: 9.306
  6 in total
  7 in total

1.  Addiction treatment agencies' use of data: a qualitative assessment.

Authors:  Jennifer P Wisdom; James H Ford Ii; Randy A Hayes; Eldon Edmundson; Kim Hoffman; Dennis McCarty
Journal:  J Behav Health Serv Res       Date:  2006-10       Impact factor: 1.505

Review 2.  Using administrative data for longitudinal substance abuse research.

Authors:  Elizabeth Evans; Christine E Grella; Debra A Murphy; Yih-Ing Hser
Journal:  J Behav Health Serv Res       Date:  2008-08-05       Impact factor: 1.505

3.  Cost evaluation of out-of-country care for patients with eating disorders in Ontario: a population-based study.

Authors:  Claire de Oliveira; Erin M Macdonald; Diane Green; Patricia Colton; Marion Olmsted; Susan Bondy; Paul Kurdyak
Journal:  CMAJ Open       Date:  2016-11-03

4.  Monitoring Utilization of a Large Scale Addiction Treatment System: The Drug and Alcohol Treatment Information System (DATIS).

Authors:  Nooshin Khobzi Rotondi; Brian Rush
Journal:  Subst Abuse       Date:  2012-06-25

5.  Levels and predictors of participation in integrated treatment programs for pregnant and parenting women with problematic substance use.

Authors:  Thao Lan Le; Chris Kenaszchuk; Karen Milligan; Karen Urbanoski
Journal:  BMC Public Health       Date:  2019-02-06       Impact factor: 3.295

6.  Cost of specialized addiction treatment of clients with fetal alcohol spectrum disorder in Canada.

Authors:  Svetlana Popova; Shannon Lange; Larry Burd; Karen Urbanoski; Jürgen Rehm
Journal:  BMC Public Health       Date:  2013-06-11       Impact factor: 3.295

7.  Identifying perceived barriers to monitoring service quality among substance abuse treatment providers in South Africa.

Authors:  Bronwyn Myers; Zainonisa Petersen; Rehana Kader; J Randy Koch; Ron Manderscheid; Rajen Govender; Charles D H Parry
Journal:  BMC Psychiatry       Date:  2014-02-05       Impact factor: 3.630
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.